[go: up one dir, main page]

HK1228311B - 用於癌症治疗的新组合物和方法 - Google Patents

用於癌症治疗的新组合物和方法 Download PDF

Info

Publication number
HK1228311B
HK1228311B HK17102284.2A HK17102284A HK1228311B HK 1228311 B HK1228311 B HK 1228311B HK 17102284 A HK17102284 A HK 17102284A HK 1228311 B HK1228311 B HK 1228311B
Authority
HK
Hong Kong
Prior art keywords
cancer
agent
subject
cells
administering
Prior art date
Application number
HK17102284.2A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1228311A1 (zh
Inventor
Jia Li Chiang
Mikule Keith
Li Youzhi
Original Assignee
Boston Biomedical, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Biomedical, Inc. filed Critical Boston Biomedical, Inc.
Publication of HK1228311A1 publication Critical patent/HK1228311A1/zh
Publication of HK1228311B publication Critical patent/HK1228311B/zh

Links

HK17102284.2A 2007-09-10 2017-03-03 用於癌症治疗的新组合物和方法 HK1228311B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20070971144P 2007-09-10
US20070013372 2007-12-13

Publications (2)

Publication Number Publication Date
HK1228311A1 HK1228311A1 (zh) 2017-11-03
HK1228311B true HK1228311B (zh) 2021-08-13

Family

ID=

Similar Documents

Publication Publication Date Title
EP3067054B1 (en) Novel compositions and methods for cancer treatment
HK1228311B (zh) 用於癌症治疗的新组合物和方法
HK1228311A1 (zh) 用於癌症治疗的新组合物和方法
ES2859699T3 (es) Composiciones y métodos novedosos para el tratamiento del cáncer
HK1227310B (zh) 类新的stat3通路抑制剂和癌干细胞通路抑制剂
HK1148906B (zh) 用於癌症治疗的组合物和方法
HK1227310A1 (zh) 类新的stat3通路抑制剂和癌干细胞通路抑制剂